Sai Life Sciences’ ₹3,042 crore IPO opens today, closing December 13. The offer includes a fresh issue and an OFS, aiming to repay debt. Priced at ₹522-549 per share, analysts advise caution due to high valuation and OFS-heavy structure, despite strong financial performance.
IndiGo Q2 Results: Loss narrows YoY to Rs 1,879 crore; revenue rises 26%
IndiGo Q2 Results: Budget airline IndiGo reported narrowing of its consolidated loss to Rs 1,879 crore in the second quarter of FY27, compared with Rs